A detailed history of Bluesphere Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bluesphere Advisors, LLC holds 4,182 shares of MRK stock, worth $407,494. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,182
Previous 4,716 11.32%
Holding current value
$407,494
Previous $583,000 18.7%
% of portfolio
0.24%
Previous 0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$111.15 - $128.97 $59,354 - $68,869
-534 Reduced 11.32%
4,182 $474,000
Q2 2024

Jul 19, 2024

BUY
$123.8 - $132.96 $133,580 - $143,463
1,079 Added 29.67%
4,716 $583,000
Q1 2024

Apr 23, 2024

BUY
$113.24 - $131.95 $226 - $263
2 Added 0.06%
3,637 $479,000
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $200 - $218
2 Added 0.06%
3,635 $396,000
Q3 2023

Oct 16, 2023

BUY
$102.95 - $114.33 $205 - $228
2 Added 0.06%
3,633 $374,000
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $217 - $236
2 Added 0.06%
3,631 $418,000
Q1 2023

Apr 21, 2023

BUY
$102.94 - $114.86 $102 - $114
1 Added 0.03%
3,629 $386,000
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $174 - $224
2 Added 0.06%
3,628 $0
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $12,003 - $13,484
142 Added 4.08%
3,626 $312,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $6,679 - $7,571
80 Added 2.35%
3,484 $318,000
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $20,435 - $22,907
278 Added 8.89%
3,404 $279,000
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $20,435 - $22,907
-278 Reduced 8.17%
3,126 $241,000
Q3 2021

Nov 03, 2021

BUY
$71.68 - $78.83 $26,593 - $29,245
371 Added 12.23%
3,404 $256,000
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $6,538 - $7,232
-93 Reduced 2.98%
3,033 $236,000
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $215,256 - $253,549
3,126 New
3,126 $241,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bluesphere Advisors, LLC Portfolio

Follow Bluesphere Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluesphere Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluesphere Advisors, LLC with notifications on news.